CardioMEMS HF System

Remote Pulmonary Pressure Monitoring

CardioMEMS HF System

Patient Selection & Assessment

Selecting the Right Patient

The CardioMEMS™ HF System is indicated for patients with:

  • NYHA Class III heart failure; and
  • One heart failure hospitalization in the past 12 months

The CardioMEMS HF System is contraindicated for patients with:

  • An inability to take dual antiplatelet or anticoagulants for one-month post implant

Patients who most commonly receive the CardioMEMS HF System are those on GDMT and those who exhibit any of the following:

  • Fluid volumes that are hard to know or manage
  • Challenging physical assessment
  • Is a patient with HFpEF or HFrEF
  • Compliant with heart failure medical care
  • Would benefit from remote monitoring if they live far from a clinic

Note: The CHAMPION trial specifically excluded patients with American College of Cardiology/ American Heart Association stage D heart failure who needed advanced therapies (i.e., left ventricular assist device, transplant or inotropic support). Even if inotropic support improved heart failure symptoms, a patient would still be defined as stage D, with refractory heart failure.1

Stages of Heart Failure

Patient Selection Resources

  • This document provides information to help you understand which of your HF patients would be good candidates for the CardioMEMS HF System.

Manuals & Resources

Manuals & Resources

Customer Service

Customer Service

This device is commercially available for use in select international markets.


  1. Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M., Costanzo, M. R., Stevenson, L. W., …Yadav, J. S., for the CHAMPION Trial Study Group. (2011). Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. The Lancet, 377(9766), 658-666.

MAT-2116103 v3.0